Jefferies Financial Group’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$879K	Sell	14,014 -254,806	-95%	-$20.4M	0.01%	978
2025 Q4	$25.6M	Sell	268,820 -33,679	-11%	-$3.3M	0.21%	156
2025 Q3	$29.5M	Buy	302,499 +44,860	+17%	+$4.65M	0.27%	110
2025 Q2	$27.7M	Buy	257,639 +168,761	+190%	+$17.1M	0.46%	88
2025 Q1	$8.97M	Sell	88,878 -248,431	-74%	-$25M	0.15%	171
2024 Q4	$30.1M	Sell	337,309 -321,497	-49%	-$28.3M	0.34%	90
2024 Q3	$55.2M	Sell	658,806 -201,574	-23%	-$15.9M	0.9%	37
2024 Q2	$66.3M	Buy	860,380 +647,731	+305%	+$47.4M	1.3%	21
2024 Q1	$14.6M	Sell	212,649 -252,494	-54%	-$16.2M	0.29%	118
2023 Q4	$26.9M	Buy	465,143 +146,602	+46%	+$7.83M	0.42%	80
2023 Q3	$16.8M	Sell	318,541 -72,493	-19%	-$3.8M	0.42%	93
2023 Q2	$21.2M	Buy	391,034 +206,696	+112%	+$10.8M	0.45%	98
2023 Q1	$9.22M	Buy	184,338 +183,304	+17,728%	+$8.64M	0.19%	225
2022 Q4	$47.8K	Buy	+1,034	New	+$44.8K	﹤0.01%	1409
2018 Q3	–	Sell	-25,000	Closed	-$817K	–	85
2018 Q2	$817K	Buy	+25,000	New	+$754K	0.06%	69